Log in

NASDAQ:NVCRNovocure News Headlines

$68.15
+6.21 (+10.03 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$61.74
Now: $68.15
$68.70
50-Day Range
$60.48
MA: $66.63
$74.41
52-Week Range
$53.40
Now: $68.15
$98.84
Volume1.33 million shs
Average Volume786,130 shs
Market Capitalization$6.84 billion
P/E Ratio757.31
Dividend YieldN/A
Beta1.56

Headlines

Novocure (NASDAQ NVCR) News Headlines

Source:
DateHeadline
Novocure Ltd (NASDAQ:NVCR) Given Average Rating of "Hold" by AnalystsNovocure Ltd (NASDAQ:NVCR) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - June 5 at 6:36 AM
Novocure Announces Launch of MyLink™ to Enable Patient-Guided, Remote Download of Optune® Usage Data - Business WireNovocure Announces Launch of MyLink™ to Enable Patient-Guided, Remote Download of Optune® Usage Data - Business Wire
www.businesswire.com - June 2 at 2:09 PM
Novocure launches MyLink tool in U.S.Novocure launches MyLink tool in U.S.
seekingalpha.com - June 2 at 9:08 AM
Novocure Announces Launch of MyLink™ to Enable Patient-Guided, Remote Download of Optune® Usage DataNovocure Announces Launch of MyLink™ to Enable Patient-Guided, Remote Download of Optune® Usage Data
finance.yahoo.com - June 2 at 9:08 AM
Novocure (NASDAQ:NVCR) Coverage Initiated by Analysts at OppenheimerNovocure (NASDAQ:NVCR) Coverage Initiated by Analysts at Oppenheimer
www.americanbankingnews.com - June 2 at 8:33 AM
Oppenheimer Begins Coverage on Novocure (NASDAQ:NVCR)Oppenheimer Begins Coverage on Novocure (NASDAQ:NVCR)
www.marketbeat.com - June 2 at 3:39 AM
Mizuho Reaffirms Buy Rating for Novocure (NASDAQ:NVCR)Mizuho Reaffirms Buy Rating for Novocure (NASDAQ:NVCR)
www.americanbankingnews.com - May 27 at 10:20 AM
Novocure Sees Unusually High Options Volume (NASDAQ:NVCR)Novocure Sees Unusually High Options Volume (NASDAQ:NVCR)
www.americanbankingnews.com - May 27 at 7:59 AM
Stock Traders Buy High Volume of Put Options on Novocure (NASDAQ:NVCR)Stock Traders Buy High Volume of Put Options on Novocure (NASDAQ:NVCR)
www.americanbankingnews.com - May 27 at 7:59 AM
Financial Contrast: Novocure (NASDAQ:NVCR) & ICU Medical (NASDAQ:ICUI)Financial Contrast: Novocure (NASDAQ:NVCR) & ICU Medical (NASDAQ:ICUI)
www.americanbankingnews.com - May 24 at 10:49 AM
$106.40 Million in Sales Expected for Novocure Ltd (NASDAQ:NVCR) This Quarter$106.40 Million in Sales Expected for Novocure Ltd (NASDAQ:NVCR) This Quarter
www.americanbankingnews.com - May 21 at 3:31 AM
Zacks: Brokerages Anticipate Novocure Ltd (NASDAQ:NVCR) to Post $0.01 Earnings Per ShareZacks: Brokerages Anticipate Novocure Ltd (NASDAQ:NVCR) to Post $0.01 Earnings Per Share
www.americanbankingnews.com - May 19 at 8:54 AM
Zai Lab (ZLAB), Novocure (NVCR) Announce China NMPA Approves Optune for Treatment of Newly Diagnosed and Recurrent Glioblastoma - StreetInsider.comZai Lab (ZLAB), Novocure (NVCR) Announce China NMPA Approves Optune for Treatment of Newly Diagnosed and Recurrent Glioblastoma - StreetInsider.com
www.streetinsider.com - May 14 at 2:32 AM
China NMPA Approves Optune® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma - GlobeNewswireChina NMPA Approves Optune® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma - GlobeNewswire
www.globenewswire.com - May 13 at 4:28 PM
NovoCure: A Long-Term Hold At A Competitive Price - Seeking AlphaNovoCure: A Long-Term Hold At A Competitive Price - Seeking Alpha
seekingalpha.com - May 13 at 1:29 AM
Form 4 NovoCure Ltd For: May 04 Filed by: DOYLE WILLIAM F - StreetInsider.comForm 4 NovoCure Ltd For: May 04 Filed by: DOYLE WILLIAM F - StreetInsider.com
www.streetinsider.com - May 6 at 9:27 PM
Is NovoCure Limited (NASDAQ:NVCR) Potentially Undervalued? - Yahoo FinanceIs NovoCure Limited (NASDAQ:NVCR) Potentially Undervalued? - Yahoo Finance
finance.yahoo.com - May 4 at 6:25 PM
Is NovoCure Limited (NASDAQ:NVCR) Potentially Undervalued?Is NovoCure Limited (NASDAQ:NVCR) Potentially Undervalued?
finance.yahoo.com - May 4 at 6:25 PM
Why MercadoLibre Stock Jumped 19.4% in April - NasdaqWhy MercadoLibre Stock Jumped 19.4% in April - Nasdaq
www.nasdaq.com - May 2 at 10:47 PM
UPDATE: Oppenheimer Downgrades NovoCure Ltd. (NVCR) to Perform - StreetInsider.comUPDATE: Oppenheimer Downgrades NovoCure Ltd. (NVCR) to Perform - StreetInsider.com
www.streetinsider.com - May 2 at 5:46 PM
NovoCure Limited (NVCR) Q1 2020 Earnings Call Transcript - The Motley FoolNovoCure Limited (NVCR) Q1 2020 Earnings Call Transcript - The Motley Fool
www.fool.com - May 2 at 5:46 PM
NovoCure Limited (NVCR) Q1 2020 Earnings Call TranscriptNovoCure Limited (NVCR) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 2 at 5:46 PM
Edited Transcript of NVCR earnings conference call or presentation 30-Apr-20 12:00pm GMT - Yahoo FinanceEdited Transcript of NVCR earnings conference call or presentation 30-Apr-20 12:00pm GMT - Yahoo Finance
finance.yahoo.com - May 1 at 4:21 AM
NovoCure Q1 2020 Earnings PreviewNovoCure Q1 2020 Earnings Preview
seekingalpha.com - April 30 at 11:15 PM
Novocure Reports First Quarter 2020 Financial Results and Provides Company UpdateNovocure Reports First Quarter 2020 Financial Results and Provides Company Update
www.businesswire.com - April 30 at 11:15 PM
Edited Transcript of NVCR earnings conference call or presentation 30-Apr-20 12:00pm GMTEdited Transcript of NVCR earnings conference call or presentation 30-Apr-20 12:00pm GMT
finance.yahoo.com - April 30 at 11:15 PM
BRIEF-Novocure Q1 Net Profit $4Mln Versus -$12.2 Mln Loss Year Ago - ReutersBRIEF-Novocure Q1 Net Profit $4Mln Versus -$12.2 Mln Loss Year Ago - Reuters
www.reuters.com - April 30 at 6:14 PM
NovoCure Limited (NVCR) CEO Asaf Danziger on Q1 2020 Results - Earnings Call Transcript - Seeking AlphaNovoCure Limited (NVCR) CEO Asaf Danziger on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - April 30 at 6:14 PM
NovoCure (NVCR) Lags Q1 Earnings and Revenue Estimates - Yahoo FinanceNovoCure (NVCR) Lags Q1 Earnings and Revenue Estimates - Yahoo Finance
finance.yahoo.com - April 30 at 6:14 PM
NovoCure (NVCR) Lags Q1 Earnings and Revenue EstimatesNovoCure (NVCR) Lags Q1 Earnings and Revenue Estimates
finance.yahoo.com - April 30 at 6:14 PM
Highly Rated Cancer Play Tumbles As Key Studies Delayed Amid OutbreakHighly Rated Cancer Play Tumbles As Key Studies Delayed Amid Outbreak
finance.yahoo.com - April 30 at 6:14 PM
Novocure Announces Presentation of EF-19 Post-approval Registry Trial Data Studying Optune as a Monotherapy for the Treatment of Recurrent GBM at the American Association for Cancer Research 2020 Virtual Annual Meeting I - Yahoo FinanceNovocure Announces Presentation of EF-19 Post-approval Registry Trial Data Studying Optune as a Monotherapy for the Treatment of Recurrent GBM at the American Association for Cancer Research 2020 Virtual Annual Meeting I - Yahoo Finance
finance.yahoo.com - April 28 at 5:11 AM
First Week of December 18th Options Trading For NovoCure (NVCR) - NasdaqFirst Week of December 18th Options Trading For NovoCure (NVCR) - Nasdaq
www.nasdaq.com - April 27 at 1:36 PM
Novocure Announces Presentation of EF-19 Post-approval Registry Trial Data Studying Optune as a Monotherapy for the Treatment of Recurrent GBM at the American Association for Cancer Research 2020 Virtual Annual Meeting I - Business WireNovocure Announces Presentation of EF-19 Post-approval Registry Trial Data Studying Optune as a Monotherapy for the Treatment of Recurrent GBM at the American Association for Cancer Research 2020 Virtual Annual Meeting I - Business Wire
www.businesswire.com - April 27 at 1:36 PM
Novocure Announces Presentation of EF-19 Post-approval Registry Trial Data Studying Optune as a Monotherapy for the Treatment of Recurrent GBM at the American Association for Cancer Research 2020 Virtual Annual Meeting INovocure Announces Presentation of EF-19 Post-approval Registry Trial Data Studying Optune as a Monotherapy for the Treatment of Recurrent GBM at the American Association for Cancer Research 2020 Virtual Annual Meeting I
finance.yahoo.com - April 27 at 8:35 AM
NovoCure (NVCR) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release - Yahoo FinanceNovoCure (NVCR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
finance.yahoo.com - April 23 at 1:28 PM
NovoCure (NVCR) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseNovoCure (NVCR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
finance.yahoo.com - April 23 at 1:28 PM
Here’s Why Growth Of Novocure’s Brain Cancer Treatment Is Only Just Starting - Motley FoolHere’s Why Growth Of Novocure’s Brain Cancer Treatment Is Only Just Starting - Motley Fool
www.fool.com - April 22 at 2:46 PM
Piper Sandler Starts NovoCure Ltd. (NVCR) at Overweight - StreetInsider.comPiper Sandler Starts NovoCure Ltd. (NVCR) at Overweight - StreetInsider.com
www.streetinsider.com - April 7 at 8:57 PM
IWM, TDOC, NVCR, AMED: ETF Outflow Alert - NasdaqIWM, TDOC, NVCR, AMED: ETF Outflow Alert - Nasdaq
www.nasdaq.com - April 7 at 3:57 PM
Is NovoCure (NASDAQ:NVCR) A Risky Investment? - Yahoo FinanceIs NovoCure (NASDAQ:NVCR) A Risky Investment? - Yahoo Finance
finance.yahoo.com - April 7 at 3:57 PM
Medical Services Outlook Bright Amid Coronavirus CrisisMedical Services Outlook Bright Amid Coronavirus Crisis
finance.yahoo.com - April 7 at 3:57 PM
Is NovoCure (NASDAQ:NVCR) A Risky Investment?Is NovoCure (NASDAQ:NVCR) A Risky Investment?
finance.yahoo.com - April 7 at 3:57 PM
Novocure (NVCR) Announces Business Update Related to COVID-19 - StreetInsider.comNovocure (NVCR) Announces Business Update Related to COVID-19 - StreetInsider.com
www.streetinsider.com - April 4 at 9:55 PM
COVID-19 throttles trial site expansion at Novocure - Seeking AlphaCOVID-19 throttles trial site expansion at Novocure - Seeking Alpha
seekingalpha.com - April 3 at 4:15 PM
BRIEF-Novocure Ltd Says At This Time, There Is No Material Impact To Cos Supply Chain - ReutersBRIEF-Novocure Ltd Says At This Time, There Is No Material Impact To Co's Supply Chain - Reuters
www.reuters.com - April 3 at 4:15 PM
Novocure Provides Business Update Related to COVID-19 - Business WireNovocure Provides Business Update Related to COVID-19 - Business Wire
www.businesswire.com - April 3 at 4:15 PM
Hedge Funds Started Selling NovoCure Limited (NVCR) Before The Coronavirus - Yahoo FinanceHedge Funds Started Selling NovoCure Limited (NVCR) Before The Coronavirus - Yahoo Finance
finance.yahoo.com - March 23 at 7:32 AM
Hedge Funds Started Selling NovoCure Limited (NVCR) Before The CoronavirusHedge Funds Started Selling NovoCure Limited (NVCR) Before The Coronavirus
finance.yahoo.com - March 23 at 7:32 AM
German Federal Joint Committee Updates Medical Care Directive to include Tumor Treating Fields, establishing National Reimbursement for Optune in GermanyGerman Federal Joint Committee Updates Medical Care Directive to include Tumor Treating Fields, establishing National Reimbursement for Optune in Germany
finance.yahoo.com - March 20 at 2:02 PM
This page was last updated on 6/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.